Skip to main content
. 2019 Jul 2;9(7):127. doi: 10.3390/metabo9070127

Table 2.

Metabolites differing significantly (q-value) between patients with AMD and controls, based on meta-analysis of the two study cohorts.

Super Pathway Sub Pathway Metabolite OR PT Pval PT OR US Pval US OR Meta Pval Meta Qval Meta
Amino Acid Methionine, Cysteine, SAM, and Taurine Metabolism Taurine 3.70 1.19 × 10−7 1.26 2.46 × 10−1 2.04 9.59 × 10−7 6.52 × 10−5
Amino Acid Glutamate Metabolism Beta−citrylglutamate 2.87 1.37 × 10−5 1.52 5.40 × 10−2 2.06 3.86 × 10−6 2.05 × 10−4
Amino Acid Tryptophan Metabolism Serotonin 2.00 6.20 × 10−4 1.58 2.67 × 10−2 1.82 4.84 × 10−5 1.65 × 10−3
Amino Acid Methionine, Cysteine, SAM, and Taurine Metabolism N−acetylmethionine 2.55 1.85 × 10−5 1.20 4.05 × 10−1 1.75 9.74 × 10−5 2.92 × 10−3
Amino Acid Alanine and Aspartate Metabolism Aspartate 2.37 6.69 × 10−5 1.28 2.32 × 10−1 1.80 1.02 × 10−4 2.92 × 10−3
Amino Acid Methionine, Cysteine, SAM, and Taurine Metabolism Hypotaurine 2.32 4.69 × 10−4 1.36 1.47 × 10−1 1.85 2.57 × 10−4 6.99 × 10−3
Amino Acid Alanine and Aspartate Metabolism N−acetylasparagine 1.55 1.96 × 10−2 2.00 4.21 × 10−3 1.69 3.22 × 10−4 7.96 × 10−3
Amino Acid Methionine, Cysteine, SAM, and Taurine Metabolism S−adenosylhomocysteine (SAH) 2.10 3.91 × 10−4 1.24 3.21 × 10−1 1.67 6.43 × 10−4 1.52 × 10−2
Carbohydrate Glycogen Metabolism Maltotriose 3.79 2.44 × 10−7 1.49 5.12 × 10−2 2.47 1.31 × 10−7 1.75 × 10−5
Carbohydrate Glycogen Metabolism Maltose 3.32 1.62 × 10−6 1.29 1.86 × 10−1 2.14 4.14 × 10−6 2.05 × 10−4
Cofactors and Vitamins Nicotinate and Nicotinamide Metabolism Nicotinamide 2.34 1.91 × 10−4 1.15 5.08 × 10−1 1.68 7.87 × 10−4 1.78 × 10−2
Lipid Phosphatidylserine (PS) 1−stearoyl−2−oleoyl−GPS (18:0/18:1) 5.74 2.94 × 10−10 1.23 2.92 × 10−1 2.35 1.80 × 10−8 6.64 × 10−6
Lipid Phospholipid Metabolism Phosphoethanolamine 3.97 2.36 × 10−8 1.44 5.79 × 10−2 2.49 2.44 × 10−8 6.64 × 10−6
Lipid Phospholipid Metabolism Choline phosphate 4.95 4.01 × 10−9 1.21 3.21 × 10−1 2.38 1.42 × 10−7 1.75 × 10−5
Lipid Sphingosines Sphingosine 16.67 1.89 × 10−9 0.99 9.68 × 10−1 1.75 2.26 × 10−6 1.36 × 10−4
Lipid Lysoplasmalogen 1-(1-enyl-palmitoyl)-GPE (P-16:0) * 1.70 5.86 × 10−3 2.47 2.98 × 10−4 1.97 1.12 × 10−5 4.69 × 10−4
Lipid Fatty Acid, Monohydroxy 14-HDoHE/17-HDoHE 5.02 8.02 × 10−9 0.87 4.63 × 10−1 1.73 3.87 × 10−5 1.46 × 10−3
Lipid Eicosanoid 12-HETE 4.77 2.61 × 10−8 0.91 6.26 × 10−1 1.64 4.03 × 10−5 1.46 × 10−3
Lipid Sphingolipid Synthesis Sphinganine 5.33 6.18 × 10−7 0.90 5.85 × 10−1 1.44 3.05 × 10−4 7.91 × 10−3
Lipid Lysoplasmalogen 1-(1-enyl-oleoyl)-GPE (P-18:1) * 1.35 9.20 × 10−2 2.01 2.36 × 10−3 1.60 1.41 × 10−3 2.95 × 10−2
Lipid Lysoplasmalogen 1-(1-enyl-stearoyl)-GPE (P-18:0) * 1.25 1.89 × 10−1 2.24 6.67 × 10−4 1.58 1.81 × 10−3 3.65 × 10−2
Nucleotide Purine Metabolism, Adenine containing Adenosine 2.58 6.33 × 10−5 2.15 6.90 × 10−4 2.39 1.60 × 10−7 1.75 × 10−5
Nucleotide Pyrimidine Metabolism, Cytidine containing Cytidine 2.55 6.24 × 10−5 2.12 1.35 × 10−3 2.37 2.93 × 10−7 2.66 × 10−5
Nucleotide Purine Metabolism, Guanine containing Guanine 3.70 5.99 × 10−7 1.39 1.08 × 10−1 2.40 8.16 × 10−7 6.34 × 10−5
Nucleotide Purine Metabolism, (Hypo)Xanthine/Inosine containing Inosine 2.29 1.54 × 10−4 1.65 9.69 × 10−3 2.02 4.74 × 10−6 2.15 × 10−4
Nucleotide Purine Metabolism, (Hypo)Xanthine/Inosine containing Hypoxanthine 2.52 3.58 × 10−5 1.24 2.79 × 10−1 1.80 8.43 × 10−5 2.70 × 10−3
Nucleotide Purine Metabolism, Adenine containing adenine 1.63 2.02 × 10−2 1.54 4.38 × 10−2 1.58 2.13 × 10−3 4.14 × 10−2
Peptide Dipeptide isoleucylglycine 2.15 1.25 × 10−4 1.07 7.26 × 10−1 1.58 1.15 × 10−3 2.51 × 10−2

Legend: OR: odds ratio; PT: Portugal; US: United States; PVal: p-value; Qval: q-value; Meta: meta-analysis; SAM - S-Adenosyl methionine.